TRIGLICLAGLAZE 30 combines three potent antidiabetic agents: Gliclazide (SR), Pioglitazone, and Metformin HCL (SR). This medication is designed to provide comprehensive glycemic control for patients with type 2 diabetes. By targeting different mechanisms of action, it helps in managing blood sugar levels effectively.
How Does It Work
- Gliclazide (SR): Stimulates the pancreas to release more insulin, helping to lower blood sugar levels.
- Pioglitazone: Improves insulin sensitivity by making body cells more responsive to insulin.
- Metformin HCL (SR): Reduces glucose production in the liver and improves insulin sensitivity in the muscles.
Uses of TRIGLICLAGLAZE 30
- Management of type 2 diabetes mellitus in adults.
- Helps in achieving better glycemic control when diet and exercise alone are insufficient.
- Used as part of a comprehensive diabetes management plan.
What is TRIGLICLAGLAZE 30
TRIGLICLAGLAZE 30 is a fixed-dose combination medication that contains Gliclazide (SR), Pioglitazone, and Metformin HCL (SR). This combination targets multiple pathways to regulate blood sugar levels, making it a valuable treatment option for patients struggling with type 2 diabetes.
Side Effects
- Common: Nausea, diarrhea, abdominal pain, and hypoglycemia.
- Less common: Weight gain, edema, and headache.
- Serious: Lactic acidosis (a rare but serious side effect of Metformin), liver dysfunction, and heart failure.
Safety Information
- Regularly monitor blood sugar levels and report any significant changes to your healthcare provider.
- Inform your doctor about any other medications or supplements you are taking to avoid potential interactions.
- Follow a balanced diet and exercise regimen as recommended by your healthcare provider.
- Do not consume alcohol excessively, as it can increase the risk of lactic acidosis and hypoglycemia.
- Notify your healthcare provider if you experience any signs of heart failure, such as shortness of breath, swelling in the legs, or sudden weight gain.